Akari Therapeutics shares are trading lower after the company announced a ratio change of its American Depository Shares from 1-representing-100 to 1-representing-2000.
Portfolio Pulse from Benzinga Newsdesk
Akari Therapeutics announced a ratio change of its American Depository Shares from 1-representing-100 to 1-representing-2000, causing its shares to trade lower.
August 15, 2023 | 4:43 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Akari Therapeutics' shares are trading lower following the announcement of a ratio change of its American Depository Shares.
The ratio change of Akari Therapeutics' American Depository Shares means that each share now represents fewer underlying shares than before. This dilutes the value of each share, leading to a decrease in the share price. As a result, the company's shares are trading lower.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100